Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma

Oncology

Volumn 75, Issue 1-2, 2008, Pages 17-26

  Zhang, Yong ^a   Fujiwara, Yoshiyuki ^a,b   Doki, Yuichiro ^a   Takiguchi, Shuji ^a   Yasuda, Takushi ^a   Miyata, Hiroshi ^a   Yamazaki, Makoto ^a   Ngan, Chew Yee ^a   Yamamoto, Hirofumi ^a   Ma, Qingyong ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Distant metastases; Gastric carcinoma; Micrometastases; TrkB; Tyrosine kinases

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CISPLATIN; FLUOROURACIL; MESSENGER RNA;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN-TYROSINE KINASES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 49849095673     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151615     Document Type: Article

References (67)

1. World Health Organization. The World Health Report 1997. http://www.who.org/whr/1997/factse.htm.
2. Maruyama K, Kaminishi N, Katai H, et al: Committee of Nationwide Registry, Japanese Gastric Cancer Association Nationwide Registry of Gastric Cancer Patients in Japan. Jpn J Cancer Clin 1999;45:719-724.
3. Roder JD, Stein HJ, Bottcher K, et al: Surgical therapy for gastric cancer. J Infus Chemother 1995;5:97-103.
4. Maehara Y, Oshiro T, Endo K, et al: Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402.
5. Okada Y, Fujiwara Y, Yamamoto H, et al: Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple marker reverse transcriptase-polymerase chain reaction assay. Cancer 2001;92:2056-2064.
6. Nakagawara A: Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 2001;169:107-114.
7. Levi-Montalcini R: The nerve growth factor 35 years later. Science 1987;237:1154-1162.
8. Klein R, Jing SQ, Nanduri V, et al: The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991;65:189-197.
9. Hisaoka M, Sheng WQ, Tanaka A, et al: Gene expression of TrkC (NTRK3) in human soft tissue tumours. J Pathol 2002;197:661-667.
10. Ricci A, Greco S, Mariotta S, et al: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 2001;25:439-446.
11. Descamps S, Lebourhis X, Delehedde M, et al: Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J Biol Chem 1998;273:16659-16662.
12. D'Onofrio M, de Grazia U, Morrone S, et al: Expression of neurotrophin receptors in normal and malignant B lymphocytes. Eur Cytokine Netw 2000;11:283-291.
13. Zhu Z, Kleeff J, Kayed H, et al: Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Mol Carcinog 2002;35:138-147.
14. Sclabas GM, Fujioka S, Schmidt C, et al: Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 2005;11:440-449.
15. Nakagawara A, Azar CG, Scavarda NJ, et al: Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 1994;14:759-767.
16. Aoyama M, Asai K, Shishikura T, et al: Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 2001;164:51-60.
17. Eggert A, Grotzer MA, Ikegaki N, et al: Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. J Clin Oncol 2001;19:689-696.
18. Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nature Rev Cancer 2003;3:203-216.
19. Bardelli A, Parsons DW, Silliman N, et al: Mutational analysis of the tyrosine kinome in colorectal cancers. Science 2003;300:949.
20. Douma S, Laar T, Zevenhoven J, et al: Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004;430:1034-1039.
21. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma (in English). Gastric Cancer 1998;1:10-24.
22. Sobin LH, Wittekind CH: TNM Classification of Malignant Tumours, ed 5. New York, Wiley, 1997, pp 59-62.
23. Labouyrie E, Dubus P, Groppi A, et al: Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol 1999;154:405-415.
24. Kaplan EL, Meier P: Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-481.
25. Cox DR: Regression models and life tables. J R Stat Soc 1972;34:187-220.
26. Agresti A, Finlay B: Logistic Regression - Modeling Categorical Responses. Statistical Methods for Social Sciences, ed 3. Upper Saddle River, Prentice Hall, 1997, pp 575-619.
27. Sakamoto Y, Ohyama S, Yamamoto J, et al: Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 2003;133:507-511.
28. Tomimatsu S, Ichikura T, Mochizuki H: Significant correlation between expression of interleukin-1α and liver metastasis in gastric carcinoma. Cancer 2001;91:1272-1276.
29. Liu ZZ, Zhu LQ, Eide FF: Critical role of TrkB and brain-derived neurotrophic factor in the differentiation and survival of retinal pigment epithelium. J Neurosci 1997;17:8749-8755.
30. Duda DG, Jain RK: Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrow. J Clin Invest 2005;115:596-598.
31. Liu Y, Encinas M, Comella JX, et al: Basic helix-loop-helix proteins bind to TrkB and p21(Cip1) promoters linking differentiation and cell cycle arrest in neuroblastoma cells. Mol Cell Biol 2004;24:2662-2672.
32. Donovan MJ, Lin MI, Wiegn P, et al: Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000;127:4531-4540.
33. + endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest 2005;115:653-663.
34. Montano X, Djamgoz MB: Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. FEBS Lett 2004;571:1-8.
35. Sclabas GM, Fujioka S, Schmidt C, et al: Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 2005;11:440-449.
36. 3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res 1999;59:2724-2730.
37. Hu Z, Sanchez-Sweatman O, Huang X, et al: Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res 2001;61:1707-1716.
38. Khwaja A, Rodriguez-Viciana P, Wennstrom S, et al: Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997;16:2783-2793.
39. Yamamoto S, Tomita Y, Hoshida Y, et al: Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol 2003;21:2537-2544.
40. Koga S, Takebayashi M, Kaibara N, et al: Pathological characteristics of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrence. J Surg Oncol 1987;36:239-242.
41. Adachi Y, Yasuda K, Inomata M, et al: Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 2000;89:1418-1424.
42. Lauren P: The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
43. Ming SC: Gastric carcinoma: a pathobiological classification. Cancer 1977;39:2475-2485.
44. Sugano H, Nakamura K, Kato Y: Pathological studies of human gastric cancer. Acta Pathol Jpn 1982;32(suppl 2):329-347.
45. Noda S, Soejima K, Inokuchi K: Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn J Surg 1980;10:277-283.
46. Adachi Y, Yasuda K, Inomata M, et al: Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 2000;89:1418-1424.
47. Mori M, Sakaguchi H, Akazawa K, et al: Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol 1995;26:504-508.
48. Sasako M: Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003;21:274s-275s.
49. Degiuli M, Sasako M, Ponti A, et al: Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 1998;16:1490-1493.
50. Maehara Y, Emi Y, Baba H, et al: Recurrences and related characteristics of gastric cancer. Br J Cancer 1996;74:975-979.
51. Lee CC, Lo SS, Wu CW, et al: Peritoneal recurrence of gastric adenocarcinoma after curative resection. Hepatogastroenterology 2003;50:1720-1722.
52. Yang ZF, Ho DW, Lam CT, et al: Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res 2005;65:219-225.
53. Zhu W, Bijur GN, Styles NA, et al: Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells. Brain Res Mol Brain Res 2004;126:45-56.
54. Du JJ, Dou KF, Peng SY, et al: Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study. World J Gastroenterol 2003;9:1431-1434.
55. Schulte JH, Schramm A, Klein-Hitpass L, et al: Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 2005;24:165-177.
56. Wang J, Lonart G, Johnson KM: Glutamate receptor activation induces carrier mediated release of endogenous GABA from rat striatal slices. J Neural Transm 1996;103:31-43.
57. Hanania T, Johnson KM: Regulation of neurotransmitter release by endogenous nitric oxide in striatal slices. Eur J Pharmacol 1998;359:111-117.
58. Stein E, Tessier-Lavigne M: Hierarchical organization of guidance receptors: silencing of netrin attraction by slit through a Robo/DCC receptor complex. Science 2001;291:1928-1938.
59. Ricci L, Felici S, Mariotta S, et al: Neurotrophin and neurotrophin receptor protein expression in the human lung. Am J Respir Cell Mol Biol 2004;30:12-19.
60. Cassiman D, Denef C, Desmet VJ, et al: Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 2001;33:148-158.
61. Dalal R, Djakiew D: Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate. Mol Cell Endocrinol 1997;134:15-22.
62. Ricci A, Greco S, Mariotta S, et al: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 2001;25:439-446.
63. Moriguchi S, Maehara Y, Korenaga D, et al: Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1992;1:341-346.
64. Yoo CH, Noh SH, Shin DW, et al: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-242.
65. Saito H, Tsujitani S, Kondo A, et al: Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma. Surgery 1999;125:195-201.
66. Marrelli D, Roviello F, de Manzoni G, et al: Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J Surg 2002;26:1160-1165.
67. Ruggeri BA, Miknyoczki SJ, Singh J, et al: Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models. Curr Med Chem 1999;6:845-857.